
Please try another search
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application. The company’s products are used for the treatment of Parkinson’s disease, organ transplantation, and liver and inflammatory bowel diseases. It serves academic institutes and pharmaceutical companies through direct and sales partners. The company was incorporated in 2013 and is headquartered in Helsinki, Finland.
Name | Age | Since | Title |
---|---|---|---|
Kari Pitkänen | 64 | 2013 | Member of Advisory Board |
Pekka Allan Antero Mattila | 65 | 2013 | Chairman of the Board |
Jonathan Kenneth Charles Knowles | 77 | - | Member of Scientific Advisory Board |
Yukako Yagi | - | - | Member of Scientific Advisory Board |
Tuomas Tenkanen | 63 | 2017 | Director |
Marilyn M. Bui | - | - | Member of Scientific Advisory Board |
Jerry Jian Hong | 50 | 2022 | Director |
Richard Haworth | - | 2024 | Member of Scientific Advisory Board |
Inti Zlobec | - | 2023 | Member of Scientific Advisory Board |
Joseph Bernardo | - | 2025 | Director |
Minna Koivula | - | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review